109 related articles for article (PubMed ID: 15053331)
1. Obesity is the major factor determining an insulin sensitivity and androgen production in women with anovulary cycles.
Dravecka I; Lazurova I; Kraus V
Bratisl Lek Listy; 2003; 104(12):393-9. PubMed ID: 15053331
[TBL] [Abstract][Full Text] [Related]
2. Metformin versus sibutramine in the treatment of hyperinsulinemia in chronically anovulating women.
Lazurova I; Dravecka I; Kraus V; Petrovicova J
Bratisl Lek Listy; 2004; 105(5-6):207-10. PubMed ID: 15535111
[TBL] [Abstract][Full Text] [Related]
3. [Hyperinsulinemia and disorders of the menstrual cycle].
Dravecká I; Lazúrová I; Kraus V; Petrovicová J; Paĺko M
Vnitr Lek; 2002 Mar; 48(3):192-6. PubMed ID: 11968579
[TBL] [Abstract][Full Text] [Related]
4. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
5. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
7. Adiponectin is independently associated with insulin sensitivity in women with polycystic ovary syndrome.
Spranger J; Möhlig M; Wegewitz U; Ristow M; Pfeiffer AF; Schill T; Schlösser HW; Brabant G; Schöfl C
Clin Endocrinol (Oxf); 2004 Dec; 61(6):738-46. PubMed ID: 15579189
[TBL] [Abstract][Full Text] [Related]
8. Adrenal androgen excess and body mass index in polycystic ovary syndrome.
Moran C; Arriaga M; Arechavaleta-Velasco F; Moran S
J Clin Endocrinol Metab; 2015 Mar; 100(3):942-50. PubMed ID: 25514100
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
[TBL] [Abstract][Full Text] [Related]
10. Comparison of clinical and laboratory characteristics of cases with polycystic ovarian syndrome based on Rotterdam's criteria and women whose only clinical signs are oligo/anovulation or hirsutism.
Hassa H; Tanir HM; Yildiz Z
Arch Gynecol Obstet; 2006 Jul; 274(4):227-32. PubMed ID: 16691383
[TBL] [Abstract][Full Text] [Related]
11. The role of adrenal hyperandrogenism, insulin resistance, and obesity in the pathogenesis of polycystic ovarian syndrome.
Rittmaster RS; Deshwal N; Lehman L
J Clin Endocrinol Metab; 1993 May; 76(5):1295-300. PubMed ID: 8388405
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
13. Correlation of plasma insulin and insulin-like growth factor-I with indices of androgen transport and metabolism in women with polycystic ovary syndrome.
Sharp PS; Kiddy DS; Reed MJ; Anyaoku V; Johnston DG; Franks S
Clin Endocrinol (Oxf); 1991 Sep; 35(3):253-7. PubMed ID: 1742883
[TBL] [Abstract][Full Text] [Related]
14. Insulin-induced capillary recruitment is impaired in both lean and obese women with PCOS.
Ketel IJ; Serné EH; Ijzerman RG; Korsen TJ; Twisk JW; Hompes PG; Smulders YM; Homburg R; Vorstermans L; Stehouwer CD; Lambalk CB
Hum Reprod; 2011 Nov; 26(11):3130-7. PubMed ID: 21920943
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
16. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
Yildiz BO; Yarali H; Oguz H; Bayraktar M
J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
[TBL] [Abstract][Full Text] [Related]
17. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
18. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like factor 3: a new circulating hormone related to luteinizing hormone-dependent ovarian hyperandrogenism in the polycystic ovary syndrome.
Gambineri A; Patton L; De Iasio R; Palladoro F; Pagotto U; Pasquali R
J Clin Endocrinol Metab; 2007 Jun; 92(6):2066-73. PubMed ID: 17356050
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitivity in women with polycystic ovary syndrome.
Vrbíková J; Cibula D; Dvoráková K; Stanická S; Sindelka G; Hill M; Fanta M; Vondra K; Skrha J
J Clin Endocrinol Metab; 2004 Jun; 89(6):2942-5. PubMed ID: 15181081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
